×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Incorporating the Patient Perspective in a Drug Development Program
Session Chair(s)
Mark Kryah, PMP
Executive Director, Program Team Leader, Program and Portfolio Management
Ultragenyx Pharmaceutical Inc., United States
This session will discuss the value of identification and incorporation of patient needs into the drug development/project management plans, including data gathering and modeling for registration clinical studies. Examples of listening and coaching skills to obtain patient insights and how those have been integrated into development/clinical programs will be shared.
Learning Objective : Describe why incorporation of patient needs is essential to drug development programs; Discuss examples of patient insights and how those insights have been integrated into drug development plans; Identify how patient needs extends beyond the development program and into the product communication strategy to patients, physicians, and payer
Speaker(s)
Why Gathering Patient Perspectives is Critical in Drug Development
Kim Ribeiro, MS
AbbVie, United States
Head, Diversity and Patient Inclusion, Clinical Development Solutions
Incorporating the Patient Perspective in a Drug Development Program
Nathan Kreischer, MS, PMP
Merck & Co. Inc., United States
Director, Global Project & Alliance Management
Have an account?